Clinical trial began to see if convalescent plasma can treat COVID-19
On Apr. 29, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine and NYU Langone…
On Apr. 29, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine and NYU Langone…
On Apr. 28, 2020, Illumina announced that the African Union Commission, on behalf of the Africa Center for…
On Apr. 28, 2020, Secarna Pharmaceuticals announced the company has entered into a cooperation with the First Affiliated…
On Apr. 28, 2020, Sarepta Therapeutics announced the Company and the USAMRIID, the Department of Defense’s lead laboratory…
On Apr. 27, 2020, RedHill Biopharma provided an additional update on the compassionate use program with its investigational…
On Apr. 27, 2020, ARTES Biotechnology, the German-based biotech company specializing in process development for recombinant vaccines, entered…
On Apr. 27, 2020, Moderna announced it had submitted an Investigational New Drug application to the U.S. Food…
On Apr. 27, 2020, Merck and the Institute for Systems Biology announced a new research collaboration to investigate…
On Apr. 24, 2020, researchers at the University of Oxford announced the start of a large, international study…
On Apr. 24, 2020, Shelly Miller, Professor of Mechanical and Environmental Engineering, University of Colorado Boulder, reported that…
On Apr. 23, 2020, a new strategic plan from the National Institute of Allergy and Infectious Diseases (NIAID),…
On Apr. 23, 2020, University of Oxford researchers announced they had begun testing a COVID-19 vaccine in human…
On Apr. 23, 2020, two significant international studies involving hundreds of scientists, including a human geneticist at the…
On Apr. 23, 2020, BioSig Technologies announced that an article titled, モThe IMPDH inhibitor merimepodib has similar antiviral…
On Apr. 23, 2020, Caladrius Biosciences announced the FDA has authorized its investigational new drug application for the…
On Apr. 22, 2020, the CDC and the USDA National Veterinary Services Laboratories announced the first confirmed cases…
On Apr. 22, 2020, the Biomedical Advanced Research and Development Authority (BARDA) and Tangen Biosciences announced teaming up…
On Apr. 20, 2020, SNBL announced their intention to participate in the development of a prophylactic DNA vaccine…
On Apr. 22, 2020, Quidel announced it has applied for an Emergency Use Authorization (EUA) for the Lyraï¾®…
On Apr. 22, 2020, researchers at Massachusetts Institute of Technology (MIT); the Ragon Institute of MGH, and Harvard…
On Apr. 22, 2020, LabCorp announced expanded serological testing for SARS-CoV-2, the virus that causes COVID-19, to more…
On Apr. 21, 2020, Immunic reported that its lead asset, IMU-838, a selective oral DHODH inhibitor successfully demonstrated…
On Apr. 20, 2020, RedHill Biopharma announced an agreement with the National Institute of Allergy and Infectious Diseases…
On Apr. 20, 2020, Anixa Biosciences announced it had entered into a strategic collaboration with OntoChem GmbH to…
On Apr. 20, 2020, Innovation Pharma reported that based on molecular screening of 11,552 compounds comprising already FDA-approved…
On Apr. 20, 2020, IDEXX Labs announced the availability of the IDEXX SARS-CoV-2 (COVID-19) RealPCR Test for pets….
On Apr. 17, 2020, the NIH announced that early treatment with the experimental antiviral drug remdesivir significantly reduced…
On Apr. 17, 2020, Roche announced the development and upcoming launch of its Elecsys Anti-SARS-CoV-2 serology test to…
On Apr. 17, 2020, the University of Washington Medicine announced that a new clinical blood test will be…
On Apr. 16, 2020, Mammoth Biosciences announced the publication of a study demonstrating the power of its platform…